retatrutide safety retatrutide clinical trials Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide UK 2026: Phase 3

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide.

Follow your prescribers plan.

At PS Labs, our research materials are supplied exclusively for scientific and analytical purposes

Limited data are available on the risk of pancreatic adverse events among people with obesity or type 2 diabetes mellitus (T2DM) initiating glucagon-like peptide-1 receptor agonist (GLP-1 RA)

Here is what qualifies and what insurance often adds.

PlexusDx offers personalized semaglutide options and genetic testing to help you find the right approach for your body